Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD Eclipse Hypodermic Needle

K-Number: K161170 · 2016-05-27

Decision Date2016-05-27
Product CodeFMI
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

BD Eclipse Hypodermic Needle is a medical device manufactured by Becton, Dickinson and Company. It received FDA 510(k) clearance on 2016-05-27 under approval number K161170. The device is classified under product code FMI. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD Eclipse Hypodermic Needle?

BD Eclipse Hypodermic Needle is a medical device that received FDA 510(k) clearance on 2016-05-27. It is manufactured by Becton, Dickinson and Company. The 510(k) number is K161170.

When was BD Eclipse Hypodermic Needle approved by the FDA?

BD Eclipse Hypodermic Needle received FDA 510(k) clearance on 2016-05-27, under approval number K161170.

What company makes BD Eclipse Hypodermic Needle?

BD Eclipse Hypodermic Needle is manufactured by Becton, Dickinson and Company.

What is the FDA product code for BD Eclipse Hypodermic Needle?

The FDA product code for BD Eclipse Hypodermic Needle is FMI.

Related Clinical Trials

Other Devices by Becton, Dickinson and Company

View all 100 devices →

Related Devices (Code: FMI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.